Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.
Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study.
复制标题
DOI：
10.1038/s41598-020-78575-w
复制
发表时间：
2020-12-10
影响因子：
4.6
通讯作者：
Jinga V
中科院分区：
文献类型：
--
作者：
Pantea Stoian A;Pricop-Jeckstadt M;Pana A;Ileanu BV;Schitea R;Geanta M;Catrinoiu D;Suceveanu AI;Serafinceanu C;Pituru S;Poiana C;Timar B;Nitipir C;Parvu S;Arsene A;Mazilu L;Toma A;Hainarosie R;Ceriello A;Rizzo M;Jinga V
关于SARS-CoV-2死亡率与基础医学状况之间关系的证据很少。我们根据罗马尼亚官方关于COVID-19死亡的地点、年龄、性别和合并症的数据进行了一项观察性、回顾性研究。我们的研究结果表明，男性、高血压、糖尿病、肥胖和慢性肾脏疾病在COVID-19死亡中最常见，疾病负担较低，样本中1年生存概率的预后较高。有证据表明，年龄依赖性的合并症对可能是SARS-CoV 2感染疾病严重程度的负性预后因素。
Evidence regarding the relation between SARS-CoV-2 mortality and the underlying medical condition is scarce. We conducted an observational, retrospective study based on Romanian official data about location, age, gender and comorbidities for COVID-19 fatalities. Our findings indicate that males, hypertension, diabetes, obesity and chronic kidney disease were most frequent in the COVID-19 fatalities, that the burden of disease was low, and that the prognosis for 1-year survival probability was high in the sample. Evidence shows that age-dependent pairs of comorbidities could be a negative prognosis factor for the severity of disease for the SARS-CoV 2 infection.
登录
查看更多内容
DOI：
10.1016/j.numecd.2020.07.031
发表时间：
2020-10-30
期刊：
Nutrition, metabolism, and cardiovascular diseases : NMCD
影响因子：
--
作者：
Di Castelnuovo A;Bonaccio M;Costanzo S;Gialluisi A;Antinori A;Berselli N;Blandi L;Bruno R;Cauda R;Guaraldi G;My I;Menicanti L;Parruti G;Patti G;Perlini S;Santilli F;Signorelli C;Stefanini GG;Vergori A;Abdeddaim A;Ageno W;Agodi A;Agostoni P;Aiello L;Al Moghazi S;Aucella F;Barbieri G;Bartoloni A;Bologna C;Bonfanti P;Brancati S;Cacciatore F;Caiano L;Cannata F;Carrozzi L;Cascio A;Cingolani A;Cipollone F;Colomba C;Crisetti A;Crosta F;Danzi GB;D'Ardes D;de Gaetano Donati K;Di Gennaro F;Di Palma G;Di Tano G;Fantoni M;Filippini T;Fioretto P;Fusco FM;Gentile I;Grisafi L;Guarnieri G;Landi F;Larizza G;Leone A;Maccagni G;Maccarella S;Mapelli M;Maragna R;Marcucci R;Maresca G;Marotta C;Marra L;Mastroianni F;Mengozzi A;Menichetti F;Milic J;Murri R;Montineri A;Mussinelli R;Mussini C;Musso M;Odone A;Olivieri M;Pasi E;Petri F;Pinchera B;Pivato CA;Pizzi R;Poletti V;Raffaelli F;Ravaglia C;Righetti G;Rognoni A;Rossato M;Rossi M;Sabena A;Salinaro F;Sangiovanni V;Sanrocco C;Scarafino A;Scorzolini L;Sgariglia R;Simeone PG;Spinoni E;Torti C;Trecarichi EM;Vezzani F;Veronesi G;Vettor R;Vianello A;Vinceti M;De Caterina R;Iacoviello L;COvid-19 RISk and Treatments (CORIST) collaboration
通讯作者：
COvid-19 RISk and Treatments (CORIST) collaboration
DOI：
10.1001/jama.2020.6775
发表时间：
2020-01-01
期刊：
JAMA, Journal of the American Medical Association
影响因子：
--
作者：
Richardson, Safiya;Hirsch, Jamie S.;,
通讯作者：
,
影响因子：
4.5
作者：
Mota, Maria;Popa, Simona Georgiana;Vlad, Adrian Radu
通讯作者：
Vlad, Adrian Radu
影响因子：
8.2
作者：
Cariou, Bertrand;Hadjadj, Samy;Gourdy, Pierre
通讯作者：
Gourdy, Pierre
影响因子：
4.5
作者：
D'Ardes D;Pontolillo M;Esposito L;Masciarelli M;Boccatonda A;Rossi I;Bucci M;Guagnano MT;Ucciferri C;Santilli F;Di Nicola M;Falasca K;Vecchiet J;Schael T;Cipollone F
通讯作者：
Cipollone F